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Alternative life cycles of Epichloe and Neotyphodium species in host grasses. The

Neotyphodium (formerly Acremonium) endophytes have only the asexual/vertical
transmission life cycle. Thus, unlike Epichloe species, the Neotyphodium species cannot
transmit contagiously; that is, they cannot transmit from an infected plant of one maternal
lineage to an uninfected plant of a different maternal lineage. However, the Neotyphodr'um

species and some Epichloe species transmit vertically at extremely high frequency, such
that 98%-] 00% of seeds produced on an endophyte-containing mother plant also contain

endophyte and, upon germination, give rise to endophyte-containing plants. Also, there
are standard methods whereby seedlings or other plant material that lacks endophyte
can be inoculated with mycelium of wild type or transformed endophyte to give rise
to endophyte-containing plants; and such plants will pass on the endophyte in the nonnal

fashions shown here depending on whether the endophyte is compatible with that host
grass and what is (are) its normal transmission mode(s) [Latch et al., [07 Annals of
Applied Biology 17 (1985)][Tsai et al., 22 Current Genet 399 (l992)].
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ENDOPHYTE ERGOT ALKALOID

More recently, a C. purpurea dmaW sequence Was disclosed

SYNTHETIC COMPOUNDS, COMPOUNDS

in TudZynski et al., 261 Molec Gen Genet 133 (1999), and

WHICH ENCODE THEREFOR AND
RELATED METHODS

is 62% identical at the DNA level to the present sequence.
Citation of the above documents is not intended as an

This application claims priority to US. Provisional
Patent Application Serial No. 60/125,490, Which Was ?led

admission that any of the foregoing is pertinent prior art. For
eXample, in some instances above, the publication Was less
than one year before the ?ling date of this patent application.

on Mar. 22, 1999.

All statements as to the date or representation as to the

The present invention Was funded in part by USDA NRI
grant 95-37303-1678; the US. Government may have cer
tain rights in this invention.

10

contents of these documents is based on subjective charac
teriZation of information available to the applicant at the
time of ?ling, and does not constitute an admission as to the
accuracy of the dates or contents of these documents.

FIELD OF THE INVENTION
SUMMARY OF THE INVENTION

The present invention relates to sequences that encode

dimethylallyl-diphosphate:L-tryptophan dimethylallyltrans
ferase (“DmaW” or “dimethylallyltryptophan synthase”), an
enZyme present in some grass endophytes, and that catalyZes
the formation of 4- y,y-dimethylallyltryptophan. This
enZyme activity is the ?rst committed step in the production
of ergot alkaloids, including those With clavine and ergoline
ring structures. Such alkaloids include clavines, lysergic

15

symbionts, thus ergot-alkaloid-de?cient plants.
It is a further object to provide methods to engineer ergot

alkaloid-de?cient endophytes.
20

acid, lysergic acid amides, and ergopeptines. The sequences

It is yet another object to provide plants With ergot
alkaloid-de?cient endophytes.
25

BACKGROUND OF THE INVENTION

by transmitting in seeds of maternal plant lineages. Repre

It is also an object of the invention to provide enZymes

useful in ergot alkaloid synthesis.
30

symbiont strains to produce ergot alkaloids.
Other objects Will be apparent from the present disclo

eXample, N. coenophialum) and Epichloe species (eg E.

ciency. Their symbioses With host grasses are characteriZed
by mutual bene?ts to the hosts and symbionts. Bene?ts to
the grass hosts include protection from insects and
vertebrates, and resistance to Water stress (drought). Anti
insect activities are mainly due to pyrrolopyraZine and

sure.

35

40

mutation or recombination, has a similar but not identical

sequence. Allelic variants typically encode proteins having
45

Tall fescue is groWn on over 14 million hectares as an

important forage, turf and conservation grass; most of the
tall fescue groWn in the US. contains ergot-alkaloid

producing endophytes. The anti vertebrate activity of the

“Allelic variant” is meant to refer to a full length gene or
partial sequence of a full length gene that occurs at essen

tially the same locus (or loci) as the referent sequence, but
Which, due to natural variations caused by, for eXample,

pyrroliZidine alkaloids produced by the endophytes. Anti
including the ergot alkaloids (clavines, lysergic acid and its

De?nitions:

For the purposes of the present application, the folloWing
terms have the folloWing meanings. All other terms have the
meaning as speci?cally recogniZed in the art.

vertebrate activities are mainly due to indole alkaloids,

derivatives, and ergopeptines).

Also, it is an object to use the present nucleic acid

compounds to determine the potential or lack of potential of

sentatives of these fungi are the Neotyphoa'ium species
(“Neotyphodium” and sometimes “Acremonium”, for

festucae and E. typhina), Which are symbionts and integral
parts of many grass cultivars. These fungi, termed
“endophytes”, are seed-transmissible at extremely high effi

It is also an object of the invention to provide materials
such as vectors for engineering ergot alkaloid-de?cient

endophytes.

Certain fungal species eXist as symbiotic and integral
parts of grasses and are passed from generation to generation
of plants, but many are not passed from plant to plant eXcept

It is yet another object to provide ergot alkaloid-de?cient
seeds.

encode a DmaW from fungi that are symbionts of commer

cially signi?cant grasses.

It is therefore an object of the present invention to provide
sequences useful to engineer ergot alkaloid-de?cient

similar activity to that of the protein encoded by the gene to
Which they are being compared. Allelic variants can also
comprise alterations in the 5‘ or 3‘ untranslated regions of the

gene (e.g., in regulatory control regions).
50

“Fragment” is meant to refer to any subset of the referent
nucleic acid sequence.

ergot alkaloids, Which manifests as “tall fescue toXicosis” in

“Knockout construct” means a DNA sequence Which has

cattle and other livestock, causes losses estimated at more

been altered via any knoWn means, for eXample, deletion,

than $600 million per year.
In 1992, Gebler and Poulter puri?ed the DmaW enZyme
from Claviceps sp. ATCC 26245 to a single protein band

insertion, point mutation or rearrangement, so as to alter or

eliminate the function of the naturally-occurring sequence
55

product, but not so as to alter the ability of the DNA

observable by SDS-PAGE electrophoresis, and fragmented

sequence to recombine With the naturally-occurring

the protein With CNBr. Gebler et al., 114 Journal of the

sequence.

American Chemical Society 7354 (1992). The three resulting
fragments Were puri?ed and their N-termini sequenced. In

Which a naturally-occurring dmaW sequence has been

research by one of the inventors of the present invention,

“Knockout mutants” are cells, embryos, fungi or plants in
60

replaced through genetic engineering With a knockout

there Was disclosed a sequence of a dmaW gene (herein

construct, so as to result in a ergot alkaloid-de?cient

dmaW) from C. fusiformis AT CC 26245 organism from

phenotype, especially a dimethylallyl-diphosphate:L

Which the sequence Was identi?ed Was mis-named C. pur

tryptophan dimethylallyltransferase- de?cient phenotype.

purea by the supplier to the ATCC, and Was actually C.
fusiformis.) Tsai et al., 216 Biochem & Biophys Res Comm
119 (1995). The C. fusiformis sequence from that research is
58% identical to the present sequences at the DNA level.

“Proteins” means any compounds Which comprise amino
65

acids, including peptides, polypeptides, fusion proteins, etc.
Moreover, for the purposes of the present invention, the
term “a” or “an” entity refers to one or more of that entity;

US 6,335,188 B1
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for example, “a protein” or “a nucleic acid molecule” refers

expressed protein. For example, substitution of valine for
leucine, arginine for lysine, or asparagine for glutamine may

to one or more of those compounds or at least one com

not cause a change in functionality of the polypeptide.
Lastly, a nucleic acid sequence homologous to the exempli
?ed nucleic acid molecules (or allelic variants or degener

pound. As such, the terms “a” (or “an”), “one or more” and
“at least one” can be used interchangeably herein. It is also
to be noted that the terms “comprising”, “including”, and
“having” can be used interchangeably. Furthermore, a com
pound “selected from the group consisting of” refers to one
or more of the compounds in the list that folloWs, including
mixtures (i.e., combinations) of tWo or more of the com

ates thereof) can have approximately 85%, preferably

approximately 90%, and most preferably approximately
95% sequence identity With a nucleic acid molecule in the

sequence listing.

biologically pure, protein or nucleic acid molecule is a
compound that has been removed from its natural milieu. As

Stringent hybridiZation conditions are determined based
on de?ned physical properties of the gene to Which the
nucleic acid molecule is being hybridiZed, and can be

such, “isolated” and “biologically pure” do not necessarily

de?ned mathematically. Stringent hybridiZation conditions

pounds. According to the present invention, an isolated, or

re?ect the extent to Which the compound has been puri?ed.
An isolated compound of the present invention can be
obtained from its natural source, can be produced using
molecular biology techniques or can be produced by chemi

10

are those experimental parameters that alloW an individual
15

cal synthesis.
BRIEF DESCRIPTION OF THE DRAWINGS

FIG. 1 schematically depicts the ?rst step of the herein
described indirect gene replacement.
FIG. 2 schematically depicts the second step of the
herein-described indirect gene replacement.
FIG. 3 schematically depicts the herein-described

20

skilled in the art to identify signi?cant similarities betWeen
heterologous nucleic acid molecules. These conditions are
Well knoWn to those skilled in the art. See, for example,

Sambrook, et al., 1989, Molecular Cloning: A Laboratory
Manual, Cold Spring Harbor Labs Press, and Meinkoth, et
al., 1984, Anal. Biochem. 138, 267-284.
It is knoWn in the art that there are commercially available

computer programs for determining the degree of similarity
betWeen tWo nucleic acid sequences. These computer pro
grams include various knoWn methods to determine the

homologous gene replacement.

percentage identity and the number and length of gaps
betWeen hybrid nucleic acid molecules. Preferred methods
to determine the percent identity among amino acid

FIG. 4 schematically depicts the alternative life cycles of
Epichloe and Neotyphodium species in host grasses.

sequences and also among nucleic acid sequences include
analysis using one or more of the commercially available

25

30

DETAILED DESCRIPTION OF THE
INVENTION

nucleic acid or amino acid sequences. These computer
programs include, but are not limited to, GCGTM (available

from Genetics Computer Group, Madison, Wis), DNAsisTM
(available from Hitachi SoftWare, San Bruno, Calif.) and

The present invention provides, inter alia, isolated nucleic
acid molecule encoding a DmaW sequence, Wherein said
nucleic acid molecule comprises a nucleic acid sequence

35

selected from the group consisting of:

MacVectorTM (available from the Eastman Kodak Company,
NeW Haven, Conn.). A preferred method to determine per
cent identity among amino acid sequences and also among

(a) a nucleic acid sequence Which has more than 63%
identity to a sequence selected from the group consist

ing of SEQ ID NO 1 and SEQ ID NO 3, and Wherein
said identity can be determined using the DNAsis
computer program and default parameters;
(b) a nucleic acid molecule selected from the group

computer programs designed to compare and analyZe

40

nucleic acid sequences includes using the Compare function
by maximum matching Within the program DNAsis Version
2.1 using default parameters.
In one embodiment of the present invention, a preferred
dmaW nucleic acid molecule includes an isolated nucleic
acid molecule Which is at least about 50 nucleotides, or at

consisting of: a nucleic acid molecule Which encodes a
least about 150 nucleotides, and Which hybridiZes under
DmaW amino acid sequence selected from the group 45 conditions Which preferably alloW about 25% base pair

consisting of: SEQ ID NO 2; SEQ ID NO 4; a protein
encoded by an allelic variant of SEQ ID NO 1; and a
protein encoded by an allelic variant of SEQ ID NO 3.

Allelic variants, fragments (including a portion of a
molecule) and homologues are, by de?nition of “nucleic

50

acid molecule”, included Within this and other embodiments.
Included Within the scope of the present invention, With
particular regard to the nucleic acids above, are allelic

variants, degenerate sequences and homologues. Allelic
variants are expected to be found in nature. The present
invention also includes variants due to laboratory

55

manipulation, such as, but not limited to, variants produced
during polymerase chain reaction ampli?cation or site
directed mutagenesis. It is also Well knoWn that there is a
substantial amount of redundancy in the various codons

60

Which code for speci?c amino acids. Therefore, this inven
tion is also directed to those nucleic acid sequences Which
contain alternative codons Which code for the eventual
translation of the identical amino acid. Also included Within
the scope of this invention are mutations either in the nucleic
acid sequence or the translated protein Which do not sub

stantially alter the ultimate physical properties of the

mismatch, more preferably under conditions Which alloW
about 20% base pair mismatch, more preferably under
conditions Which alloW about 15% base pair mismatch,
more preferably under conditions Which alloW about 10%
base pair mismatch and even more preferably under condi
tions Which alloW about 5% base pair mismatch With a
nucleic acid molecule selected from the group consisting of
SEQ ID NO 1 and SEQ ID NO 3.
Another embodiment of the present invention includes a
nucleic acid molecule comprising at least about 150 base
pairs, Wherein the nucleic acid molecule hybridiZes, in a
solution comprising 1X SSC and 0% formamide, at a
temperature of about 56° C., to a nucleic acid sequence
selected from the group consisting of: SEQ ID NO 1 and
SEQ ID NO 3. Also preferred are fragments of any of such
nucleic acid molecules.
Additional preferred dmaW nucleic acid molecules of the
present invention include an isolated nucleic acid molecule
Which is at least about 50 nucleotides, or at least about 150

65

nucleotides, comprising a nucleic acid sequence that is
preferably at least about 65% identical, more preferably
about 70% identical, more preferably about 75% identical,

US 6,335,188 B1
5

6

more preferably about 80% identical, more preferably about
85% identical, more preferably about 90% identical and

Would be a useful knockout construct. Moreover, excision of

even more preferably about 95% identical to a nucleic acid

sequence selected from the group consisting of SEQ ID NO
1 and SEQ ID NO 3. Also preferred are fragments of any of
such nucleic acid molecules. Percent identity may be deter

5

endophyte transformed With knockout constructs are con

mined using the Compare function by maximum matching

sidered Within the present invention. Particularly preferred

Within the program DNAsis Version 2.1 using default

are: forage, turf and conservation grasses. These include, for

parameters.
Vectors Which comprise the above molecules are Within
the scope of the present invention, as are endophytes and
other fungi transformed With the above sequences as are

10

used for these purposes, are the ryegrasses such as perennial

sequences. Vectors may be obtained from various commer

Alto, Calif), Stratagene (La Jolla, Calif), Invitrogen
(Carlsbad, Calif.), NeW England Biolabs (Beverly, Mass.)
and Promega (Madison, Wis).

15

Preferred vectors are those Which are capable of transfer

ring the molecules disclosed herein into fungal cells. A

20

vector Which provided for either an early or late promoter in

conjunction With the present sequences Would be useful in
certain circumstances. For instance, the folloWing promoters
Would be useful in early expression of the present
sequences:

25

glyceraldehyde-3-phosphate dehydrogenase gene pro
moter [Jungehiilsing et al., 25 Current Genetics 101

(1994)].
trpC promoter [Yelton et al., 82 Proceedings of the
National Academy of Sciences of the United States of

30

America 834 (1985)].

ics 399 (1992)].
These are fungal promoters that are knoWn to Work in
35

purpurea.
In order to then constitutively express the sequences

described above, the construct optionally contains, for
example, a beta-tubulin promoter according to the procee
dures in Tsai et al., 22 Current Genetics 399 (1992).
Moreover, the most commercially signi?cant use of the
present invention is in the construction of “knockout
mutants” using the above sequences, or knoWn sequences,
for design and construction of DmaW-de?cient mutants. In
other Words, the present invention is informative to those

40

45

naturally-occurring sequence inactive. For example, the

bine. The mutated version of the sequence is then introduced
into cells of a preferred line via routine methods (i.e.
biolistic processes, electroporation, treatment of Wall-less

alkaloid is Within the scope of the present invention. Of
course, those in the art recogniZe that any seed, embryo or
plant With endophyte transformed With knockout constructs
Which are useful for producing plants for biomass are Within
the scope of the present invention.
Transformation of cells With the nucleic acid molecules of
the present invention can be accomplished according to

knoWn procedures. The folloWing procedures are Well
knoWn: electroporation [Tsai et al., 22 Current Genetics 399
(1992)], treatment of Wall-less fungal cells With vector DNA
plus CaCl2 and polyethyleneglycol [Yelton et al., 81 Pro
ceedings of the National Academy of Sciences of the United
States of America 1470 (1984)], and biolistics [Armaleo et
al., 17 Current Genetics 97 (1990)]. In addition, fungi have
Biotechnology 598 (1999)]. The transformed cells are also
Within the scope of this invention.
The transformed cells may be groWn into a fungal myce

lium (thallus), Which in turn gives rise to spores. Fungal
mycelium and spores are propagated inde?nitely. In
addition, transformed fungal endophyte can be introduced
into grass plants. The current preferred method to introduce
the fungus into plant is by inoculation of seedling meristems
[Latch and Christensen, 107 Annals of Applied Biology 17
(1985)]. Another knoWn method is inoculation and regen
eration of plant tissue culture [Johnson et al., 70 Plant
Disease 380 (1986)].
Once introduced into a plant the endophyte Will remain

inde?nitely and propagate inside all plant propagules includ
ing tillers, stolons, and seeds (unless procedures are under

skilled in the art as to their usefulness in making the

above sequences can be mutated by any means, i.e., deletion,
insertion, point mutation, rearrangement, etc, so long as the
mutated version or sequences nearby in replicatable DNA of
the fungus (e.g. chromosome) retains the ability to recom

ryegrass (Lolium perenne). All these have endophytes and
most such endophytes produce ergot alkaloids. In particular,
tall fescues are most preferred. HoWever, any seed, embryo
or plant Which comprise endophytes Which produce ergot

been transformed using vector-containing bacterial strains,
namely Agrobacterium tumefaciens [Gouka et al., 17 Nature

beta-tubulin gene promoter [Tsai et al., 22 Current Genet

endophytes or (for the glyceraldehyde-3-phosphate dehy
drogenase gene promoter) the related fungus Claviceps

example, tall fescue (Festuca arundinacea), meadoW fescue
(Festuca pratensis), and red fescue (Festuca rubra), Which
are common turf, conservation (to hold soil and reclaim strip
mines) and forage grasses in the US. and WorldWide. Also

plants having endophytes transformed With the above
cial sources, including Clontech Laboratories, Inc. (Palo

the coding region or replacing the coding region With a
antibiotic (i.e. hygromycin) resistance gene Would be useful.
FIGS. 1 through 3 describe examples of such manipulations.
For example, the folloWing seeds, embryos or plants With

taken to eliminate live fungal mycelium in the grass, for
50

example by long storage of seeds at ambient temperature).
In any grass breeding Where the female plant possesses the
endophyte the seeds Will almost all possess the identical
endophyte, and those seeds Will give rise to plants With that

endophyte [Siegel et al., 74 Phytopathology 932 (1984)]. In
55

this Way a grass variety With transformed endophyte can be

developed, propagated, and planted for forage, pasture, turf,

cells With vector, Agrobacterium-mediated transformation,
etc.). DmaW-de?cient mutants of the preferred line Would

revegetation, or soil conservation.

then be selected and propagated. These “knockout” mutant
embryos, seeds and plants are Within the scope of the present

sequences With the ability to knockout the above sequences,

Therefore, also provided are methods for constructing

In particular, sequences near the active site of enZyme

comprising one of the folloWing techniques: inserting a
foreign piece of DNA into one of the disclosed sequences;
deleting a piece of DNA from one of the disclosed

function, and the site itself, Would be preferred targets.

sequences; or creating a mutation such that the DmaW

invention, as are the knockout constructs, i.e. sequences and

60

vectors.

activity is eliminated.

Moreover, sequences Which are conserved among related

organisms are also preferred targets. It is contemplated that
a modi?cation of the present invention such that the start

Also provided are antisense constructs and methods to
inhibit translation or accumulation of mRNA transcripts of

codon has been eliminated, or replaced With a stop codon,

the disclosed sequences, so as to either eliminate or reduce

65

US 6,335,188 B1
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the amount of sequence product. The procedures for anti

There are also provided recombinant cells comprising the
nucleic acid molecules and/or proteins herein described.
Proteins Which Would result from expression of the
nucleic acid molecules herein disclosed are preferred, With
the proteins Which Would result from expression of the

sense inhibition for mRNA are described in US. Pat. No.

5,554,743, Which patent is expressly incorporated by refer
ence into this application. Alternatively, the present inven
tion could be used to design riboZymes Which speci?cally
cleave dmaW mRNA.
Also provided in the present invention are methods to

exempli?ed nucleic acid molecules being most preferred. It
is understood that proteins Which Would result from expres
sion of allelic variants of the exempli?ed sequences, as Well
as proteins Which Would result from the expression of

express or overexpress the dmaW sequences described

herein, and using the DmaW in pharmaceutical processes.
Ergot alkaloids produced in fungal fermentation or chemi
cally modi?ed ergot alkaloids from fungal fermentation are

10

nucleic acid molecules Which hybridiZe under stringent
hybridiZation conditions to the nucleic acid molecules exem
pli?ed are Within the scope of the present invention as Well.

Well knoWn pharmaceuticals. The dmaW gene can be intro

duced into an ergot alkaloid-producing fungal strain, for
example of C. purpurea, thus increasing the copy number
and potentially the expression of the DmaW protein. Utili

Lastly, an amino acid sequence substantially homologous to

a referent dmaW-encoded protein Will have at least 85%
Zation of a constitutive promoter such as for beta-tubulin 15 sequence identity, preferably 90%, and most preferably 95%

[Tsai et al., 22 Current Genetics 399 (1992)] may help
increase expression of the gene and, thus, of the protein.
Because DmaW catalyZes the rate limiting step of ergot
alkaloid synthesis in C. purpurea [Lee et al., 177 Archives of
Biochemistry & Biophysics 84 (1976)], its increased expres

sequence identity With the amino acid sequence of a referent
dmaW-encoded protein or a peptide thereof. For example, an

amino acid sequence is substantially homologous to dmaW

encoded protein if, When aligned With dmaW-encoded
20

sion may increase ergot alkaloid production. The loW level
of sequence identity betWeen dmaW from different genera

proteins.

(for example betWeen dmaW sequences of Neotyphodium
and Claviceps) Will reduce the problem knoWn as quenching
or cosuppression Which limits production of gene products
in fungi and plants [Cogoni et al., 65 Antonie Van Leeu
Wenhoek International Journal of Microbiology 205 (1994)].

DmaW homologs can be the result of natural allelic
variation or natural mutation. DmaW homologs of the
25

present invention can also be produced using techniques
knoWn in the art including, but not limited to, direct modi
?cations to the protein or modi?cations to the gene encoding

Overexpression can be as skill of the art, in particular,
according to the procedures described in US. Pat. No.

5,477,001.

protein, at least 85% of its amino acid residues are the same.
SEQ ID NO 2 and SEQ ID NO 4 are the most preferred

the protein using, for example, classic or recombinant
nucleic acid techniques to effect random or targeted
30

mutagenesis.

Also provided in the present invention are methods to
EXAMPLE

identify Neotyphodium or Acremonium or Epichloe fungi
that lack dmaW and, therefore, are unlikely to produce ergot

Example 1

alkaloids. The cloned Neotyphodium genes can be used for

standard Southern blot hybridiZation, by anyone skilled in

35

the art, to screen these related fungi for the presence of

homologous genes. In addition, degenerate primers can be
used for polymerase chain reaction under conditions
described to amplify segments of dmaW from fungi in
family Clavicipitaceae or from Neotyphodium or Acremo

genomic DNA fragments from N. coenophialum by poly
merase chain reaction (PCR). A (+) means they correspond
40

nium species. The ampli?ed segments can be analyZed by
gel electrophoresis and sequence analysis by anyone skilled
in the art. Fungi that lack DmaW can then be introduced into

grass plants and thereby incorporated into breeding lines as
described above.

45

Transformation of plant endophytes With these sequences
Would be according to knoWn procedures as described
above. Plants can be groWn according to knoWn procedures.
Lastly, the present sequences are useful to identify related
sequences, such as those from Balansia, Balansiopsis,

Obtaining dmaW sequence from N. coenophialum
The folloWing degenerate primers Were used to amplify
in sequence to a portion of mRNA, thus read 5‘—3‘ on the
gene, and a (—) indicates they are reverse complements of a
portion of the mRNA and read 3‘—5‘ on the gene: thus, each
PCR involved a combination of a (+) and a (—) primer.
dmaWdeg(+)1: GAR CAR MGN YTN TGG TGG CA
dmaWdeg(+)2: GGN ATH TTY AAR AAR CAY AT
dmaWdeg(-)3: AR NGT CCA NAR RTC YTC CAT
dmaWdeg(-)4: TA NAC YTG NGG YTC NGG CAT
N=A,G,C or T; Y=C or T; R=A or G; M=A or C; H=A,
T or C.

50

Four PCR reactions Were performed to amplify fragments

Echinodothis, Atkinsonella, Myriogenospora,

from each fungus, using four different primer combinations,

Neotyphodium, and Parepichloe, or natural or induced

dmaWdeg(+)1 and dmaWdeg(-)3, dmaWdeg(+)1 and
dmaWdeg(-)4, dmaWdeg(+)2 and dmaWdeg(-)3,

mutants. For example, screening could be by Southern blot

hybridiZation analysis of genomic DNA or by polymerase
chain reaction using DNA oligonucleotide primers targeted

55

to dmaW or the locus that contains it.

The present invention also provides isolated proteins

dGTP, dTTP and dCTP), 25 mM each primer, 1 X PCR
buffer (Perkin-Elmer), and 2.5 units Taq DNA polymerase
(AmpliTaq Gold from Perkin-Elmer). Reactions Were held

encoded by a dmaW sequence, Wherein said proteins com
prise an amino acid sequence selected from the group

consisting of:

60

(a) an amino acid sequence Which has more than 68%
identity to an amino acid sequence selected from the

group consisting of SEQ ID NO 2 and SEQ ID NO 4
and Wherein said identity can be determined using the
DNAsis computer program and default parameters; and
(b) an amino acid sequence Which is encoded by a nucleic
acid sequence of claim 1.

dmaWdeg(+)2 and dmaWdeg(-)4. Each 50 microL reaction
mixture contained 200ng fungal genomic DNA template,
200 microM each deoxyribonucleotide triphosphate (dATP,

at 93 ° C. for 9 min and 95° C. for 3 min, then subjected to

35 cycles of the folloWing pro?le: 94° C. for 45 s, 53° C. for
45 s, 72° C. for 80 s in a Perkin-Elmer model 2400 Thermal

Cycler. After completing these temperature cycles the reac
tions Were incubated 5 min at 72° C., then analyZed by
65

agarose gel electrophoresis.
The resulting ampli?ed genomic fragments Were cloned
and used as probes of a cosmid library (and thus obtained

US 6,335,188 B1
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SEQ ID NO 1 of N. coenophialum dmaW), or the sequences

alkaloid synthetic properties of the endophyte/grass sym

Were used as a basis for neW primers for anchored single

biosis Will be determined by standard chemical methods.

primer PCR (and thus obtained SEQ ID NO 3 of N.

coenophialum dmaW).

Example 3

Clones Were sequenced using PE Biosystems Model 310 5

Genetic Analyzer. DNA sequence analysis ‘Was ‘carried out

Identity Comparisons

With the DNAs1s (Hitachi) and GCG (University of Wis
consin Genetics Computer Group, Madison) sequence
The GAP program of the Wisconsin Genetics Group GCG
analysis packages. Alignment of sequences Was done using
package Was used to compare the original sequence from
CLUSTALW according to Thompson et al., 22 Nucl. Acids 10 ATCC 26245 (C. fusiformis) With SEQ ID NO 1 and SEQ
Res. 4673 (1994).
ID NO 3, and likeWise With the C. purpurea ATCC 20102
dmaW gene (sequenced by the present lab, and identical to
Example 2
the sequence published by TudZynski et al, cited in
_
Constructlon of knockout mutants

Clones Will be constructed containing DNA of each
dmaW
deleted,locus
or in from
WhichWhich
the dmaW
all orhas
partbeen
of the
mutated
gene tohasa form
been
eXpected to be inactive. These clones Will be used in

Background). Comparisons both With nucleic acid and With
15 amino acid sequences Were made, though for hybridiZation

anaiysls 03?, £1136 nillglggalcld ldenllltg?ls lhmpzgtatiie' in
eacl 621,5;
n 3 233152;:
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transformation experiments as described in Tsai et al, 22 2O fei?eilc; tlttls 121%? zggzgm 152713: 872;‘? tt'l t fot? ??léac
Genetics 399 (1992). Transformants Will be screened by

Southern blot hybridiZation and polymerase chain reaction
to identify those that have had the Wild type gene replaced

200102120
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an

'

0 O

a 0
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gene‘
Although the present invention has been fully described

by the mutant form. In endophytes With more than one
herein, it is to be noted that various changes and modi?ca
dmaW copy, such as N. coenophialum, the procedure Will be 25 tions are apparent to those skilled in the art. Such changes
repeated until all active or potentially active copies are
and modi?cations are to be understood as included Within
replaced With inactive forms. The endophyte, so altered, Will
the scope of the present invention as de?ned by the
be introduced into its natural host, and the loss of ergot
appended claims.

SEQUENCE LISTING

<l60> NUMBER OF SEQ ID NOS: 6

<210> SEQ ID NO 1
<2ll> LENGTH: 1347
<2 12> TYPE: DNA

<2 13> ORGANISM: Neotyphodium coenophialum
<400> SEQUENCE: 1

atggtaatgg caaagacact ccaccaggaa gtttatcata cccttagcga aacatttgac

60

tttgccaaca atgaccagag gctatggtgg cacagcacgg cgccaatgtt cgaaaagatg

120

ctccaaactg ctaactatag cattgatgct cagtatcgac atctgggcat ttataagagc

180

catgtcattc cttttcttgg tgtctatcct acaagaagtg gcgagcggtg gctaagcatt

240

cttacgagat acggaacccc gtttgagcta agtcttaatt gctcggactc cgtagttcgg

300

tatacatacg agcctattaa cgccgcaact ggcagtcatc tggatccgtt taacactttc

360

gctatctggg aggccctgaa aaagcatatt gagtcccagc caggcataga ccttgaatgg

420

ttttcttact ttaaacaaga gcttacactt gacgcaaacg agtccacgta cctgcactcg

480

caaaacttgg ttaaggaaca gatcaaaact caaaacaagc tcgctttgga ccttaaaggt

540

gacaagttcg tactgaagac ctacatctac cccgaattga agtccgtcgc aactggtaaa

600

tcggtccagg agctcgtgtt tggctccgtc cgcaagctag cgcagaagca caagagtatc

660

cgtcctgcct ttgaaatgct agaagactat gtccagtctc gcaataaatt ctctaccacg

720

gatgacagtc acaatactct attatcttca cgccttctct cttgcgacct gataagtcct

780

accaagtctc gtgtcaagat ctacctcctg gaacgaatgg tctcgttgcc agcgatggaa

840

gatctttgga cgcttggcgg ccgtcgagaa gatcagtcca ctattgaggg attggagatg

900

US 6,335,188 B1
11

12
-oontinued

atccgagaac tttggggtct cctcaacatg tctcctggtt tgcgcgccta ccctgagcct
tacttgcccc tcggcgccat tcccaatgag caacttccgt ccatggccaa

960

ttacacctta

1020

gtgtacttta ctgtgttcgg catgaatgat

1080

atggaggtga ctaatgcact cacgacattc ttcatgaggc atgaatggag cgatatggca

1140

agtaaataca aagcctgcct cagggaatct ttcccgcatc atgattacga agccctgaat

1200

caccataatg

atcccatacc agaaccgcaa

tatatccact

cgtacatttc

agccatattt aagtgtgtat

1260

ctccactcct

ttgaaactgg taaatggcca gtgtttcccg aaggtctaat agcatttgac

1320

cttctcctac cgaaagaaca

gcatgccggc gagatttaac ttgttaa

1347

SEQ ID NO 2
LENGTH: 448
TYPE: PRT
ORGANISM: Neotyphodium

coenophialum

SEQUENCE: 2
Met Val Met Ala

Lys Thr

Leu His Gln Glu Val

1

Tyr His Thr

10

Glu Thr Phe

Asp Phe Ala

Asn Asn

20

15

Asp Gln Arg

Lys

35

50

Met Leu Gln Thr Ala Asn

Leu

Gly

Phe Leu
65

Gly

Leu Thr

Arg Tyr Gly Thr

Tyr

Pro Thr

Tyr

Ser Ile

45

Ile

Tyr Lys

55

Val

Trp Trp His Ser
30

40

Asp Ala Gln Tyr Arg His

Ser His Val Ile Pro

60

Arg

Ser

Gly

Glu
75

Arg Trp

Pro Phe Glu Leu Ser Leu Asn

85
Ser Val Val

Leu

25

Thr Ala Pro Met Phe Glu

Leu Ser

Leu Ser Ile

Cys

90

Ser

Asp

95

Arg Tyr Thr Tyr Glu

Pro Ile Asn Ala Ala Thr

100

105

Gly Ser

110

His Leu Asp Pro Phe Asn Thr Phe Ala Ile Trp Glu Ala Leu Lys Lys
115

120

His Ile Glu Ser Gln Pro
130

Gly

Ile

125

Asp

Lys Gln Glu

Leu Thr Leu

145

Asp Ala

Asn Glu Ser Thr

Lys Glu Gln Ile Lys Thr Gln

Lys

Lys Gly Asp Lys Phe Val
Ser Val Ala Thr

Gly Lys

195
Ser Val

Lys Thr Tyr Ile Tyr
190

Ser Val Gln Glu Leu Val

Ser

Arg

Pro Ala Phe

Lys Phe

Ser Thr Thr

Ser Ile

Arg

Asn

Arg

240
Leu Leu Ser

250
Ser

Leu Leu

265

Met Val Ser Leu Pro Ala Met Glu

Asp

280
Ser Thr Ile Glu

Cys Asp
255

Arg Val Lys Ile Tyr

260

Arg Glu Asp Gln

Phe Gly

235

245

Lys

Pro Glu

205

Ser His Asn Thr Leu Leu Ser Ser

275

Leu Ala Leu

185

230

Leu Ile Ser Pro Thr

Lys

220

Asp Tyr Val Gln

225

Asp Asp

Asn

175

215

Glu Met Leu Glu

Leu His Ser

Leu

Lys His Lys

Leu Ala

210

Tyr Phe

160

200

Arg Lys

Tyr

170

180
Leu

Ser

155

165
Leu

Trp Phe
140

150

Gln Asn Leu Val

Asp

Leu Glu

135

Glu Arg

270
Leu

Trp Thr

Leu

Gly Gly Arg

285

Gly

Leu Glu Met Ile

Arg

Glu Leu

US 6,335,188 B1
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290

295

300

Trp Gly Leu Leu Asn Met Ser Pro Gly Leu Arg Ala Tyr Pro Glu Pro
305

310

315

320

Tyr Leu Pro Leu Gly Ala Ile Pro Asn Glu Gln Leu Pro Ser Met Ala
325
330
335

Asn Tyr Thr Leu His His Asn Asp Pro Ile Pro Glu Pro Gln Val Tyr
340

345

350

Phe Thr Val Phe Gly Met Asn Asp Met Glu Val Thr Asn Ala Leu Thr
355

360

365

Thr Phe Phe Met Arg His Glu Trp Ser Asp Met Ala Ser Lys Tyr Lys
370

375

380

Ala Cys Leu Arg Glu Ser Phe Pro His His Asp Tyr Glu Ala Leu Asn
385

390

395

400

Tyr Ile His Ser Tyr Ile Ser Phe Ser Tyr Arg Lys Asn Lys Pro Tyr
405

410

415

Leu Ser Val Tyr Leu His Ser Phe Glu Thr Gly Lys Trp Pro Val Phe
420

425

430

Pro Glu Gly Leu Ile Ala Phe Asp Ala Cys Arg Arg Asp Leu Thr Cys
435

440

445

<2 10> SEQ ID NO 3
<211> LENGTH: 1353
<212> TYPE: DNA

<213> ORGANISM: Neotyphodium coenophialum
<400> SEQUENCE: 3

atggtattgg caaagacact ccaccaggaa gtttatcaaa ccctcagcga aacatttgac

60

tttgccaaca atgaccagag gctatggtgg cacagcacgg cgccaatgtt ccaaaagata

120

ctccaaactg ctaactatag catttatgct cagtatcaac atctgagcat ttataaaagc

180

catatcattc cttttcttgg tgtctatcct acaagaagtg gcgagcggtg gctaagcatt

240

cttacgagat acggaacccc gtttgagcta agtcttaatt gctctgactc catagttcgg

300

tatacatacg agcctattaa cgccgcaact ggcagccatc tggatccgtt caacactttc

360

gctatctggg aggctctaaa aaagcttata gattcccagc caggcataga ccttcaatgg

420

ttttcctact ttaaacaaga gcttacactt gacgcaaacg agtccacgta cctgcactct

480

caaaacttgg tcaaggaaca gatcaaaact caaaacaagc tagcgttaga ccttaaaggt

540

gacaagttcg tactcaagac ctacatctac cccgaattga agtccgtcgc aactggtaaa

600

tcggtccagg agcttgtgtt tggctccgtc cgcaagctag cgcagaagca taagagtatc

660

cgtcctgcct ttgaaatgct agaagactat gtccagtctc gcaataaagt ccctaccacg

720

gatgacagtc acaatactcc attatcttca cgccttctct cttgcgacct ggtgagtcct

780

accaagtctc gtgtcaagat ctacctcctg gaacgaatgg tctcgttgcc agcgatggaa

840

gatctttgga cgcttggcgg ccgtcgagaa gatcagtcca ctattgaggg attggagatg

900

atccgagaac tttggggtct ccttaacatg tctcctggtt tgcgcgccta ccctgagcct

960

tacttgcccc tcggcgccat tcccaatgag caacttccgt ccatggccaa ttacacctta

1020

caccataatg atccgatacc agaaccgcaa gtgtacttta ctgtgttcgg catgaatgat

1080

atggaggtga ctaatgcact cacgaaattc ttcatgaggc atgaatggag cgatatggca

1140

agtaaataca aagcctgcct tagggaatct ttcccgcatc ataattacga agccctaaat

1200

tatatccact cgtacatttc cttctcctac cgaaataaca agccatattt aagtgtgtat

1260

US 6,335,188 B1
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ctccactcat ttgaaactgg tgaatggcct gtgtttcccg aaggtctaat agcttttgac

1320

ggatgccggc gagatttaac ttgttataag tag

1353

<2l0> SEQ ID NO 4
<211> LENGTH: 450
<212> TYPE: PRT

<213> ORGANISM: Neotyphodium coenophialum
<400> SEQUENCE: 4
Met Val Leu Ala Lys Thr Leu His Gln Glu Val Tyr Gln Thr Leu Ser
1
5
10
15

Glu Thr Phe Asp Phe Ala Asn Asn Asp Gln Arg Leu Trp Trp His Ser
20

25

30

Thr Ala Pro Met Phe Gln Lys Ile Leu Gln Thr Ala Asn Tyr Ser Ile
35
40
45

Tyr Ala Gln Tyr Gln His Leu Ser Ile Tyr Lys Ser His Ile Ile Pro
50

55

6O

Phe Leu Gly Val Tyr Pro Thr Arg Ser Gly Glu Arg Trp Leu Ser Ile
65

70

75

80

Leu Thr Arg Tyr Gly Thr Pro Phe Glu Leu Ser Leu Asn Cys Ser Asp
85

90

95

Ser Ile Val Arg Tyr Thr Tyr Glu Pro Ile Asn Ala Ala Thr Gly Ser
100

105

110

His Leu Asp Pro Phe Asn Thr Phe Ala Ile Trp Glu Ala Leu Lys Lys
115

120

125

Leu Ile Asp Ser Gln Pro Gly Ile Asp Leu Gln Trp Phe Ser Tyr Phe
130
135
140
Lys Gln Glu Leu Thr Leu Asp Ala Asn Glu Ser Thr Tyr Leu His Ser
145

150

155

160

Gln Asn Leu Val Lys Glu Gln Ile Lys Thr Gln Asn Lys Leu Ala Leu
165

170

175

Asp Leu Lys Gly Asp Lys Phe Val Leu Lys Thr Tyr Ile Tyr Pro Glu
180

185

190

Leu Lys Ser Val Ala Thr Gly Lys Ser Val Gln Glu Leu Val Phe Gly
195

200

205

Ser Val Arg Lys Leu Ala Gln Lys His Lys Ser Ile Arg Pro Ala Phe
210

215

220

Glu Met Leu Glu Asp Tyr Val Gln Ser Arg Asn Lys Val Pro Thr Thr
225

230

235

240

Asp Asp Ser His Asn Thr Pro Leu Ser Ser Arg Leu Leu Ser Cys Asp
245

250

255

Leu Val Ser Pro Thr Lys Ser Arg Val Lys Ile Tyr Leu Leu Glu Arg
260

265

270

Met Val Ser Leu Pro Ala Met Glu Asp Leu Trp Thr Leu Gly Gly Arg
275

280

285

Arg Glu Asp Gln Ser Thr Ile Glu Gly Leu Glu Met Ile Arg Glu Leu
290

295

300

Trp Gly Leu Leu Asn Met Ser Pro Gly Leu Arg Ala Tyr Pro Glu Pro
305

310

315

320

Tyr Leu Pro Leu Gly Ala Ile Pro Asn Glu Gln Leu Pro Ser Met Ala
325
330
335

Asn Tyr Thr Leu His His Asn Asp Pro Ile Pro Glu Pro Gln Val Tyr
340

345

350

Phe Thr Val Phe Gly Met Asn Asp Met Glu Val Thr Asn Ala Leu Thr

US 6,335,188 B1
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355

360

365

Lys Phe Phe Met Arg His Glu Trp Ser Asp Met Ala Ser Lys Tyr Lys
370

375

380

Ala Cys Leu Arg Glu Ser Phe Pro His His Asn Tyr Glu Ala Leu Asn
385

390

395

400

Tyr Ile His Ser Tyr Ile Ser Phe Ser Tyr Arg Asn Asn Lys Pro Tyr
405

410

415

Leu Ser Val Tyr Leu His Ser Phe Glu Thr Gly Glu Trp Pro Val Phe
420

425

430

Pro Glu Gly Leu Ile Ala Phe Asp Gly Cys Arg Arg Asp Leu Thr Cys
435

440

445

Tyr Lys
450

<2 10> SEQ ID NO 5
<211> LENGTH: 1908
<212> TYPE: DNA

<213> ORGANISM: Neotyphodium coenophialum
<400> SEQUENCE: 5

gcattgctac ttcgctaaga agttttcttt taagttgtgt agggatttat tggatgaaac

60

cttagctagt tggctaataa tcttggaggc taggcagcaa aaccctgatt cttactatgc

120

tacatgtata atagacttcc tcagatatta atttcaaacc atgtttgcct gttagttctc

180

tctagcgcaa aggtgacttg ttagaccaca atttgttcaa tctttaactg tatcaaagaa

240

acagacaggg ctattacgct cgtcctcttc ttcacaatgg taatggcaaa gacactccac

300

caggaagttt atcataccct tagcgaaaca tttgactttg ccaacaatga ccagaggcta

360

tggtggcaca gcacggcgcc aatgttcgaa aagatgctcc aaactgctaa ctatagcatt

420

gatgctcagt atcgacatct gggcatttat aagagccatg tcattccttt tcttggtgtc

480

tatcctacaa gaagtggcga gcggtggcta agcattctta cgagatacgg aaccccgttt

540

gagctaagtc ttaattgctc ggactccgta gttcggtata catacgagcc tattaacgcc

600

gcaactggca gtcatctgga tccgtttaac actttcgcta tctgggaggc cctgaaaaag

660

catattgagt cccagccagg catagacctt gaatggtttt cttactttaa acaagagctt

720

acacttgacg caaacgagtc cacgtacctg cactcgcaaa acttggttaa ggaacagatc

780

aaaactcaaa acaagctcgc tttggacctt aaaggtgaca agttcgtact gaagacctac

840

atctaccccg aattgaagtc cgtcgcaact ggtaaatcgg tccaggagct cgtgtttggc

900

tccgtccgca agctagcgca gaagcacaag agtatccgtc ctgcctttga aatgctagaa

960

gactatgtcc agtctcgcaa taaattctct accacggatg acagtcacaa tactctatta

1020

tcttcacgcc ttctctcttg cgacctgata agtcctacca agtctcgtgt caagatctac

1080

ctcctggaac gaatggtctc gttgccagcg atggaagatc tttggacgct tggcggccgt

1140

cgagaagatc agtccactat tgagggattg gagatgatcc gagaactttg gggtctcctc

1200

aacatgtctc ctggtttgcg cgcctaccct gagccttact tgcccctcgg cgccattccc

1260

aatgagcaac ttccgtccat ggccaattac accttacacc ataatgatcc cataccagaa

1320

ccgcaagtgt actttactgt gttcggcatg aatgatatgg aggtgactaa tgcactcacg

1380

acattcttca tgaggcatga atggagcgat atggcaagta aatacaaagc ctgcctcagg

1440

gaatctttgt aagtgatatc ccagctctca cattgcatga caagagttac taacataaaa

1500

atcgcttggc agcccgcatc atgattacga agccctgaat tatatccact cgtacatttc

1560
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13. A method of claim 12, Wherein said sample endophyte

What is claimed is:
1. An isolated nucleic acid molecule, Wherein said nucleic
acid molecule comprises a nucleic acid sequence selected

is used in commercial plants selected from the group con

from the group consisting of:
(a) a nucleic acid molecule encoding a dimethylallyltryp

conservation.
14. A method for producing increased amount of ergot

sisting of forage, pasture, turf, land reclamation, and soil
alkaloids, comprising eXpressing the nucleic acid molecule

tophan synthase (DmaW molecule) Which has more

according to claim 1 in a host fungal cell, so the copy
number of messenger RNA derived from transcription of
said nucleic acid molecule is increased, and alloWing said

than 70% identity to a molecule selected from the

group consisting of SEQ ID NO 1 and SEQ ID NO 3,
and Wherein said identity can be determined using the
DNAsis computer program and default parameters;
(b) a nucleic acid molecule selected from the group

10

consisting of: a nucleic acid molecule Which encodes a
DmaW amino acid molecule selected from the group

consisting of: SEQ ID NO 2; and SEQ ID NO 4; and
(c) a nucleic acid molecule fully complementary to a
nucleic acid molecule selected from the group consist
ing of: a nucleic acid molecule of (a); and a nucleic acid
molecule of

15

. A knockout construct of a dmaW molecule of claim 1.
20
. A vector comprising a knockout construct of claim 2.

A fungus comprising a knockout construct of claim 2.
A seed comprising a fungus of claim 4.

An embryo comprising a fungus of claim 4.
A plant comprising a fungus of claim 4.
. A plant of claim 7, Which is a forage grass.
. A plant of claim 8, Which is a fescue.

10. A plant of claim 9, Which is a Festuca arundinacea.
11. A method to express DmaW in a cell, comprising
transforming a cell With a molecule of claim 1; and incu
bating said cell under such conditions so as to cause expres

sion of DmaW.
12. A method to identify endophytes that contain or lack
a dmaW gene, comprising contacting a nucleic acid mol
ecule of claim 1 With DNA of a sample endophyte under
l><SSC and 0% formamide at about 56° C. hybridiZation

Wash conditions, and determining if said endophyte contains
or lacks the dmaW gene based on the results of the hybrid
iZation reaction.

25

30

35

host fungal cell to groW under appropriate groWth
conditions, Which causes increased production of ergot
alkaloid.
15. The isolated nucleic acid molecule according to claim
1, Wherein said nucleic acid molecule encoding a DmaW
molecule has more than 75% identity to the nucleic acid
molecule having the sequence set forth in SEQ ID NO: 1 or
SEQ ID NO:3.
16. The isolated nucleic acid molecule according to claim
1, Wherein said nucleic acid molecule encoding a DmaW
molecule has more than 80% identity to the nucleic acid
molecule having the sequence set forth in SEQ ID NO:1 or
SEQ ID NO:3.
17. The isolated nucleic acid molecule according to claim
1, Wherein said nucleic acid molecule encoding a DmaW
molecule has more than 85% identity to the nucleic acid
molecule having the sequence set forth in SEQ ID NO:1 or
SEQ ID NO:3.
18. The isolated nucleic acid molecule according to claim
1, Wherein said nucleic acid molecule encoding a DmaW
molecule has more than 90% identity to the nucleic acid
molecule having the sequence set forth in SEQ ID NO:1 or
SEQ ID NO:3.
19. The isolated nucleic acid molecule according to claim
1, Wherein said nucleic acid molecule encoding a DmaW
molecule has more than 95% identity to the nucleic acid
molecule having the sequence set forth in SEQ ID NO:1 or
SEQ ID NO:3.

